Investigator
Memorial Sloan Kettering Cancer Center
Ongoing genome doubling shapes evolvability and immunity in ovarian cancer
Single-cell whole-genome sequencing of 30,260 tumour genomes from 70 samples across 41 patients in the SPECTRUM cohort reveals that ongoing whole-genome doubling drives tumour evolvability and immune evasion in high-grade serous ovarian cancer.
Researcher
